$4565 | SAVE $805 | Single User
$5024 | SAVE $886 | Five User License
$6630 | SAVE $1,170 | Enterprise License

Coronary Stents Market by Product, Biomaterials {Metallic, Polymeric, and Natural Biomaterials, End User - Global Opportunity Analysis and Industry Forecast, 2014-2022

Coronary Stents Market by Product (Drug-eluting Stent, Bare-metal Stent, and Bioabsorbable Vascular Stent), Biomaterials {Metallic (Cobalt Chromium, Platinum Chromium, Nickel Chromium, and Stainless Steel), Polymeric, and Natural Biomaterials), End User (Hospital & Clinic and Ambulatory Surgical Centers) - Global Opportunity Analysis and Industry Forecast, 2014-2022
[Lowest Price Guaranteed: $4,565]

Published by Allied Market Research: 04 Apr 2017 | 103499 | In Stock
Related Topics: Abbott , Biomaterial , Drug , Life , Medical , Platinum , Steel , Stent , Vascular

Introduction

Coronary stents are small expandable tubes that are used to treat narrowed or blocked coronary arteries and reduce chest pain (angina). Patients with coronary artery disease (CAD) are treated with these stents. These types of stents are also called as cardiac stents and consist of metallic mesh. These coronary stents are implanted in narrowed coronary artery during percutaneous coronary intervention (PCI).nnIncrease in incidence of CAD, emergence of innovative coronary stents, and improved clinical outcomes due to stenting drive the market growth. In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes and obesity, and improved insurance & reimbursement supplement the market growth. However, availability of alternative methods for coronary heart disease treatment and high cost of treatment-associated coronary stents hamper the market growth. Furthermore, the untapped emerging countries present lucrative opportunities for the market. The global coronary stents market accounted for ,806 million in 2015, and is anticipated to reach at ,003 million by 2022, registering a CAGR of 9.5% from 2016 to 2022.nnThe global coronary stents market is segmented based on product, biomaterial, end user, and geography. Based on product, it is classified into drug-eluting stent, bare-metal stent, and bio-absorbable vascular stent. On the basis of biomaterial, it is categorized into metallic, polymeric, and natural biomaterial. Metallic stents are further classified to cobalt chromium (CoCr), platinum chromium (Pt-Cr), stainless steel, and nickel titanium. Based on end user, it is divided into hospital & clinic and ambulatory surgical centers.nnGeographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific accounted for the highest market share in the coronary stents market in 2015, and is expected to retain its dominance throughout the forecast period, owing to the increase in demand for advanced healthcare services in emerging countries (India and China). In addition, with the withdrawal of Johnson & Johnson’s stents business in 2011, the market players from China and other Asia-Pacific countries have got an opportunity to accelerate in the global market. However, LAMEA is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in healthcare facilities, available disposable income, and rapid development in economic conditions.nnProduct development is the key strategy adopted by the market players. The report provides a comprehensive analysis of the key players that operate in the global coronary stents market.nnKEY MARKET BENEFITSnnnnThe study provides an in-depth analysis of the global coronary stents market and the current trends and future estimations to elucidate the imminent investment pockets from 2014 to 2022.nnThe report presents quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities.nnExtensive analysis of the market based on product type assists in understanding the trends in the industry.nnKey market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.nnnCoronary Stents Market Key Segments:nnBy ProductnnnnDrug-Eluting StentnnBare-Metal StentnnBio-absorbable Vascular StentnnnBy BiomaterialnnnnMetallicnnnnnnCobalt Chromium (CoCr)nnnPlatinum Chromium (Pt-Cr)nnnStainless SteelnnnNickel TitaniumnnnnnnPolymeric BiomaterialnnNatural BiomaterialnnnBy End UsernnnnHospital & ClinicnnAmbulatory Surgical CentersnnnBy GeographynnnnNorth AmericannnnnnU.S.nnnCanadannnMexiconnnnnnEuropennnnnGermanynnnFrancennnUKnnnItalynnnSpainnnnRest of EuropennnnnnAsia-PacificnnnnnJapannnnChinannnAustraliannnIndiannnSouth KoreannnRest of Asia-PacificnnnnnnLAMEAnnnnnBrazilnnnSouth AfricannnEgyptnnnRest of LAMEAnnnnnnnKEY PLAYERS PROFILEDnnnnAbbott LaboratoriesnnB. Braun Melsungen AGnnBoston Scientific CorporationnnC. R. Bard, Inc.nnMicroport Scientific CorporationnnTerumo CorporationnnMedtronic plc.nnBiotronik SE & Co. KGnnBiosensors International Group, Ltd.nnStentys SAnnnOther players in the value chain include (profiles not included in the report)nnnnMeril Life Sciences Pvt. Ltd.nnVascular Concepts LimitednnTranslumina GmbHnnREVA Medical, Inc.nnElixir Medical Corporationn

Table of Contents
for Coronary Stents Market by Product (Drug-eluting Stent, Bare-metal Stent, and Bioabsorbable Vascular Stent), Biomaterials {Metallic (Cobalt Chromium, Platinum Chromium, Nickel Chromium, and Stainless Steel), Polymeric, and Natural Biomaterials), End User (Hospital & Clinic and Ambulatory Surgical Centers) - Global Opportunity Analysis and Industry Forecast, 2014-2022

  • CHAPTER 1 INTRODUCTION

    1.1. REPORT DESCRIPTION
    1.2. KEY BENEFITS FOR STAKEHOLDERS
    1.3. KEY MARKET SEGMENTS
    1.4. RESEARCH METHODOLOGY

    1.4.1. Secondary research
    1.4.2. Primary research
    1.4.3. Analyst tools and models

    CHAPTER 2 EXECUTIVE SUMMARY

    2.1. KEY FINDINGS OF THE STUDY
    2.2. CXO PERSPECTIVE

    CHAPTER 3 MARKET OVERVIEW

    3.1. MARKET DEFINITION AND SCOPE
    3.2. KEY FINDINGS

    3.2.1. Top investment pockets
    3.2.1. Top winning strategies

    3.2.1.1. Competitive intelligence of companies and their strategies

    3.2.2. Market share analysis, 2016

    3.3. MARKET DYNAMICS

    3.3.1. Drivers

    3.3.1.1. Emergence of newer trend in the field of coronary stents
    3.3.1.2. Improved clinical outcomes with stenting
    3.3.1.3. Rise in prevalence of coronary heart disease
    3.3.1.4. Improved insurance and reimbursement

    3.3.2. Restraints

    3.3.2.1. Availability of alternative treatment methods for coronary heart disease
    3.3.2.2. High cost of treatment associated with stent implants
    3.3.2.3. Stringent approval process for stents

    3.3.3. Opportunities

    3.3.3.1. Huge market opportunities in the developing countries

    3.4. PORTERS FIVE FORCES ANALYSIS

    3.4.1. Bargaining power of buyers
    3.4.1. Bargaining power of suppliers
    3.4.2. Threat of substitutes
    3.4.3. Threat of new entrants
    3.4.4. Competitive rivalry

    3.5. CLINICAL TRIALS

    CHAPTER 4 GLOBAL CORONARY STENTS MARKET, BY PRODUCT

    4.1. OVERVIEW

    4.1.1. Market size and forecast

    4.2. DRUG-ELUTING STENTS (DES)

    4.2.1. Key market trends
    4.2.2. Key growth factors and opportunities
    4.2.3. Market size and forecast

    4.3. BARE-METAL CORONARY STENTS

    4.3.1. Key market trends
    4.3.2. Key growth factors and opportunities
    4.3.1. Market size and forecast

    4.4. BIOABSORBABLE STENTS

    4.4.1. Key market trends
    4.4.2. Key growth factors and opportunities
    4.4.1. Market size and forecast

    CHAPTER 5 GLOBAL CORONARY STENT MARKET, BY BIOMATERIALS

    5.1. OVERVIEW

    5.1.1. Market size and forecast

    5.2. METALLIC BIOMATERIALS

    5.2.1. Market size and forecast

    5.3. POLYMERIC BIOMATERIALS

    5.3.1. Market size and forecast

    5.4. NATURAL BIOMATERIALS

    5.4.1. Market size and forecast

    CHAPTER 6 GLOBAL CORONARY STENTS MARKET, BY END USER

    6.1. OVERVIEW

    6.1.1. Market size and forecast

    6.2. HOSPITALS

    6.2.1. Market size and forecast

    6.3. AMBULATORY SURGICAL CENTERS

    6.3.1. Market size and forecast

    CHAPTER 7 GLOBAL CORONARY STENTS MARKET, BY GEOGRAPHY

    7.1. OVERVIEW

    7.1.1. Market size and forecast

    7.2. NORTH AMERICA

    7.2.1. Key market trends
    7.2.2. Key growth factors and opportunities
    7.2.3. Market size and forecast
    7.2.4. U.S. market size and forecast
    7.2.5. Canada market size and forecast
    7.2.6. Mexico market size and forecast

    7.3. EUROPE

    7.3.1. Key market trends
    7.3.2. Key growth factors and opportunities
    7.3.3. Market size and forecast
    7.3.4. Germany market size and forecast
    7.3.5. France market size and forecast
    7.3.6. Italy market size and forecast
    7.3.7. Spain market size and forecast
    7.3.8. Rest of Europe market size and forecast

    7.4. ASIA-PACIFIC

    7.4.1. Key market trends
    7.4.2. Key growth factors and opportunities
    7.4.3. Market size and forecast
    7.4.4. Japan market size and forecast
    7.4.5. China market size and forecast
    7.4.6. India market size and forecast
    7.4.7. Australia market size and forecast
    7.4.8. Malaysia market size and forecast
    7.4.9. Rest of Asia-Pacific market size and forecast

    7.5. LAMEA

    7.5.1. Key market trends
    7.5.2. Key growth factors and opportunities
    7.5.3. Market size and forecast
    7.5.4. Brazil market size and forecast
    7.5.5. South Africa market size and forecast
    7.5.6. South Arabia market size and forecast
    7.5.7. Rest of LAMEA market size and forecast

    CHAPTER 8 COMPANY PROFILES

    8.1. ABBOTT LABORATORIES

    8.1.1. Overview
    8.1.2. Operating business segments
    8.1.3. Business performance
    8.1.4. Key strategic moves and developments

    8.2. B. BRAUN MELSUNGEN AG.

    8.2.1. Company overview
    8.2.2. Operating business segments
    8.2.3. Business performance
    8.2.4. Key strategic moves and developments

    8.3. BIOSENSORS INTERNATIONAL GROUP, LTD.

    8.3.1. Overview
    8.3.2. Operating business segments
    8.3.3. Business performance
    8.3.4. Key strategic moves and developments

    8.4. BIOTRONIK SE & CO. KG

    8.4.1. Company overview
    8.4.2. Operating business segments
    8.4.3. Key strategic moves and developments

    8.5. BOSTON SCIENTIFIC CORPORATION

    8.5.1. Overview
    8.5.2. Operating business segments
    8.5.3. Business performance
    8.5.4. Key strategic moves and developments

    8.6. C. R. BARD, INC.

    8.6.1. Company overview
    8.6.2. Operating business segments
    8.6.3. Business performance
    8.6.4. Key strategic moves and developments

    8.7. MEDTRONIC PLC.

    8.7.1. Overview
    8.7.2. Operating business segments
    8.7.3. Business performance
    8.7.4. Key strategic moves and developments

    8.8. MICROPORT SCIENTIFIC CORPORATION

    8.8.1. Company Overview
    8.8.2. Operating business segments
    8.8.3. Business performance
    8.8.4. Key strategic moves and developments

    8.9. STENTYS SA

    8.9.1. Company overview
    8.9.2. Operating business segments
    8.9.3. Business performance
    8.9.4. Key strategic moves and developments

    8.10. TERUMO CORPORATION

    8.10.1. Overview
    8.10.2. Operating business segments
    8.10.3. Business performance
    8.10.4. Key strategic moves and developments

    LIST OF TABLES

    TABLE 1. PREVALENCE OF CORONARY HEART DISEASE IN INDIA (2010-2015)
    TABLE 2. GLOBAL CORONARY STENTS MARKET, BY TYPE, 2014-2022 ($MILLION)
    TABLE 3. GLOBAL DRUG-ELUTING STENTS MARKET, BY REGION, 2014-2022 ($MILLION)
    TABLE 4. GLOBAL BARE-METAL STENTS MARKET, BY REGION, 2014-2022 ($MILLION)
    TABLE 5. GLOBAL BIOABSORBALE STENTS MARKET, BY REGION, 2014-2022 ($MILLION)
    TABLE 6. GLOBAL CORONARY STENTS MARKET, BY BIOMATERIALS, 2014-2022 ($MILLION)
    TABLE 7. GLOBAL METALLIC BIOMATERIALS MARKET, BY REGION, 2014-2022 ($MILLION)
    TABLE 8. GLOBAL POLYMERIC BIOMATERIALS MARKET, BY REGION, 2014-2022 ($MILLION)
    TABLE 9. GLOBAL NATURAL BIOMATERIALS MARKET, BY REGION, 2014-2022 ($MILLION)
    TABLE 10. GLOBAL CORONARY STENTS MARKET, BY END USER, 2014-2022
    TABLE 11. GLOBAL HOSPITALS MARKET, BY REGION, 2014-2022
    TABLE 12. GLOBAL AMBULATORY SURGICAL CENTERS MARKET, BY REGION, 2014-2022
    TABLE 13. GLOBAL CORONARY STENTS MARKET, BY REGIONS, 2014-2022 ($MILLION)
    TABLE 14. NORTH AMERICA CORONARY STENTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
    TABLE 15. NORTH AMERICA CORONARY STENTS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
    TABLE 16. NORTH AMERICA CORONARY STENTS MARKET, BY BIOMATERIALS 2014-2022 ($MILLION)
    TABLE 17. NORTH AMERICA CORONARY STENTS MARKET, BY END USER 2014-2022 ($MILLION)
    TABLE 18. COMPETITIVE LANDSCAPE IN EUROPE
    TABLE 19. EUROPE CORONARY STENTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
    TABLE 20. EUROPE CORONARY STENTS MARKET, BY PRODUCT 2014-2022 ($MILLION)
    TABLE 21. EUROPE CORONARY STENTS MARKET, BY BIOMATERIALS 2014-2022 ($MILLION)
    TABLE 22. EUROPE CORONARY STENTS MARKET, BY END USER 2014-2022 ($MILLION)
    TABLE 23. ASIA-PACIFIC CORONARY STENTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
    TABLE 24. ASIA-PACIFIC CORONARY STENTS MARKET, BY PRODUCT 2014-2022 ($MILLION)
    TABLE 25. ASIA-PACIFIC CORONARY STENTS MARKET, BY BIOMATERIALS 2014-2022 ($MILLION)
    TABLE 26. ASIA-PACIFIC CORONARY STENTS MARKET, BY END USER 2014-2022 ($MILLION)
    TABLE 27. LAMEA CORONARY STENTS MARKET, BY COUNTRY, 2014-2022 ($MILLION)
    TABLE 28. LAMEA CORONARY STENTS MARKET, BY PRODUCT, 2014-2022 ($MILLION)
    TABLE 29. LAMEA CORONARY STENTS MARKET, BY BIOMATERIALS, 2014-2022 ($MILLION)
    TABLE 30. LAMEA CORONARY STENTS MARKET, BY END USER, 2014-2022 ($MILLION)
    TABLE 31. ABBOTT: COMPANY SNAPSHOT
    TABLE 32. ABBOTT: OPERATING SEGMENTS
    TABLE 33. B. BRAUN: COMPANY SNAPSHOT
    TABLE 34. B. BRAUN: OPERATING SEGMENTS
    TABLE 35. BIOTRONIK: COMPANY SNAPSHOT
    TABLE 36. BIOTRONIK: OPERATING SEGMENTS
    TABLE 37. BOSTON: COMPANY SNAPSHOT
    TABLE 38. BOSTON: OPERATING SEGMENTS
    TABLE 39. BARD: COMPANY SNAPSHOT
    TABLE 40. BARD: OPERATING SEGMENTS
    TABLE 41. MEDTRONIC: COMPANY SNAPSHOT
    TABLE 42. MEDTRONIC: OPERATING SEGMENTS
    TABLE 43. MICROPORT: COMPANY SNAPSHOT
    TABLE 44. MICROPORT: OPERATING SEGMENTS
    TABLE 45. STENTYS: COMPANY SNAPSHOT
    TABLE 46. STENTYS : OPERATING SEGMENTS
    TABLE 47. TERUMO: COMPANY SNAPSHOT
    TABLE 48. TERUMO: OPERATING SEGMENTS

    LIST OF FIGURES

    FIGURE 1. CORONARY STENTS MARKET SEGMENTATION
    FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL CORONARY STENTS MARKET
    FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
    FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
    FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
    FIGURE 6. TOP COMPANIES AND NATURE OF THEIR STRATEGIES
    FIGURE 7. TOP COMPANIES AND TYPE OF THEIR STRATEGIES
    FIGURE 8. MARKET SHARE ANALYSIS: CORONARY STENTS MARKET, 2015
    FIGURE 9. BARGAINING POWER OF BUYERS, 2015
    FIGURE 10. BARGAINING POWER OF SUPPLIERS, 2015
    FIGURE 11. THREAT OF SUBSTITUTES, 2015
    FIGURE 12. THREAT OF NEW ENTRANTS, 2015
    FIGURE 13. COMPETITIVE RIVALRY, 2015
    FIGURE 14. CLINICAL TRIALS FOR CORONARY STENTS (%)
    FIGURE 15. GLOBAL CORONARY STENTS MARKET, BY TYPE
    FIGURE 16. U.S. CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 17. CANADA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 18. MEXICO CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 19. GERMANY CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 20. FRANCE CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 21. ITALY CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 22. SPAIN CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 23. REST OF EUROPE CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 24. JAPAN CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 25. CHINA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 26. INDIA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 27. AUSTRALIA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 28. MALAYSIA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 29. REST OF ASIA-PACIFIC CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 30. BRAZIL CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 31. SOUTH AFRICA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 32. SOUTH ARABIA CORONARY STENTS MARKET, 2014-2022 ($MILLION)
    FIGURE 33. REST OF LAMEA CORONARY STENTS MARKET, 2014-2022 ($MILLION)

Additional Details

Publisher

Allied Market Research

Publisher Information

Reference

103499 | LI172187

Number of Pages

151

Report Format

PDF

Allied Market Research Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! Global Coronary Artery Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Nov 2016 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! Global Coronary Artery Disease Partnering 2010 to 2016
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce...
01 Oct 2016 by Current Partnering USD $1,271 (normally
USD $1,495)
More Info
SAVE 15% today! EpiCast Report: Acute Coronary Syndrome - Epidemiology Forecast to 2025
EpiCast Report: Acute Coronary Syndrome - Epidemiology Forecast to 2025SummaryAcute coronary syndrom...
08 Aug 2016 by Global Data USD $3,396 (normally
USD $3,995)
More Info
SAVE 15% today! Coronary Stenosis Global Clinical Trials Review, H2, 2016
Coronary Stenosis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, ...
29 Jul 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016
Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinica...
29 Jul 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Medical Devices Pipeline Assessment, 2016
Percutaneous Transluminal Coronary Angioplasty Drug Eluting Balloon (DEB) Catheters - Medical Device...
01 Jun 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2016
Coronary Artery Bypass Graft Surgery - Medical Devices Pipeline Assessment, 2016SummaryGlobalData's ...
15 Apr 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2015
Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 20...
23 Dec 2015 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Coronary Disease Global Clinical Trials Review, H2, 2015
Coronary Disease Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report, “...
23 Dec 2015 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! Percutaneous Coronary Intervention Global Clinical Trials Review, H2, 2015
Percutaneous Coronary Intervention Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinic...
23 Dec 2015 by Global Data USD $2,125 (normally
USD $2,500)
More Info

This report is published by Allied Market Research

Download Free Report Summary PDF

Coronary Stents Market by Product (Drug-eluting Stent, Bare-metal Stent, and Bioabsorbable Vascular Stent), Biomaterials {Metallic (Cobalt Chromium, Platinum Chromium, Nickel Chromium, and Stainless Steel), Polymeric, and Natural Biomaterials), End User (Hospital & Clinic and Ambulatory Surgical Centers) - Global Opportunity Analysis and Industry Forecast, 2014-2022 | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...